InMed Pharmaceuticals Inc (INM)

InMed Pharmaceuticals Inc (INM) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.6M; returns 1 day +8.3%, 1 week +9.1%, 1 year -29.1%.

InMed Pharmaceuticals Inc. (INM) is a clinical-stage biopharmaceutical company focused on developing small molecule therapeutics targeting diseases with high unmet medical needs, particularly in neurodegenerative disorders and dermatological conditions.

Groups INM belongs to

• Canada Companies
• Biotechnology
• Pharmaceuticals
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Healthcare
• Neuroscience
• Unmet Medical Needs
• Neurological Disorders
• Alzheimer's Disease
• Cannabis

INM financial model: income statement, cash flow and balance sheet